Semaglutide

Semaglutide is a synthetic GLP-1 (glucagon-like peptide-1) receptor agonist and one of the most extensively characterized peptide compounds in current endocrine and metabolic research. Structurally optimized for extended half-life and receptor binding affinity, Semaglutide has been investigated for its role in insulin secretion modulation, appetite regulation, glucose homeostasis, and lipid metabolism — making it a cornerstone compound for studying the GLP-1 signaling axis.

GLP-1 receptor agonist — precise mechanism for investigating insulin signaling, appetite regulation & energy balance
Extended half-life — structurally optimized for sustained receptor engagement in research models
Glucose & lipid metabolism — studied for its role in glycemic control and metabolic homeostasis
≥99% purity — HPLC-verified, every batch
Flexible dosing — SM2 to SM50, matched to your protocol

Main Benefits:

• Activates GLP-1 receptors — studied for insulin secretion and beta-cell function research
• Investigated for appetite suppression and energy intake regulation pathways
• Supports glucose homeostasis research in metabolic and endocrine models
• Lipid metabolism modulation — studied for effects on triglycerides and cholesterol pathways
• Lyophilized format — stable, consistent reconstitution and extended shelf life

For Research Use Only.